GeneMedicine
Latest round
- Series B
Last raised
- Jul 2021
Total raised
- $43M
Investors
- 10
About GeneMedicine
Founded in 2014 and based in Seoul, South Korea, Genemedicine operates as a biotechnology company that develops anti-cancer drugs based on adenovirus genetic manipulation technologies.45 billion post-money. GeneMedicine offers a pipeline of potential treatments, with ongoing research and development efforts focused on various types of cancer. Their research content covers a wide range of areas, including viral vector design, optimization of delivery mechanisms, and clinical trials. In addition to its R&D activities, GeneMedicine also operates a Contract Development and Manufacturing Organization (CDMO/CMO) business. This division provides services to other pharmaceutical and biotechnology companies, offering expertise in viral vector production and process development.
Who invested in GeneMedicine
10 investors across 2 rounds
See all investors in GeneMedicine
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about GeneMedicine
Who invested in GeneMedicine?
GeneMedicine has 10 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has GeneMedicine raised?
GeneMedicine has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did GeneMedicine last raise money?
GeneMedicine's most recent round on record is a Series B, in Jul 2021.
What does GeneMedicine do?
Founded in 2014 and based in Seoul, South Korea, Genemedicine operates as a biotechnology company that develops anti-cancer drugs based on adenovirus genetic manipulation technologies.
Where is GeneMedicine headquartered?
GeneMedicine is headquartered in Seoul, South Korea.
Which VCs invest in companies like GeneMedicine?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at GeneMedicine's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like GeneMedicine? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.